Atlas Trials

Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed Influenza

Clinical trial NCT00192413 · COMPLETED

Trial details

NCT number
NCT00192413
Sponsor
MedImmune LLC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Influenza
Start date
2002-03-01
Primary completion
2002-11-01
Enrollment
3009

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.